Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C

AIM OF THE STUDY: Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) incidence will be diminishing due to use of direct acting antiviral agents (DAA), but there is still constant risk for HCC development. Elevated serum g-glutamyl transpeptidase (GGT) activity is associated with increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Orzechowska, Dorota, Klimowicz, Katarzyna, Stępień, Anna, Mikuła, Tomasz, Sapuła, Mariusz, Wiercińska-Drapało, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122098/
https://www.ncbi.nlm.nih.gov/pubmed/34027121
http://dx.doi.org/10.5114/ceh.2021.104466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122098/
https://www.ncbi.nlm.nih.gov/pubmed/34027121
http://dx.doi.org/10.5114/ceh.2021.104466

Ejemplares similares